Close

MRK Financial Facts

Restructuring costs: 545.6M
Net Income: 8.08B
See Full Income Statement

Total Assets: 41.75B
Total Merck & Co., Inc. stockholders' equity: 15.87B
See Full Balance Sheet

Merck & Co. Inc. (MRK) Earnings

  |   Expand Research on MRK
Next EPS Date 2/3/23 *Est. EPS Growth Rate +5.7% *Last Qtr.
Average EPS % Beat Rate +12.3% Revenue Growth Rate +13.6% *Last Qtr.
Average % Move 1-Wk after EPS -1.2% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/27/22 Q322 $1.85$1.75 +$0.10$15B$14.07B = Details
7/28/22 Q222 $1.87$1.68 +$0.19$14.6B$13.83B = Details
4/28/22 Q122 $2.14$1.83 +$0.31$15.9B$14.71B = Details
2/3/22 Q421 $1.80$1.56 +$0.24$13.5B$13.46B = Details
10/28/21 Q321 $1.75$1.55 +$0.20$13.2B$12.33B Details
7/29/21 Q221 $1.31$1.48 -$0.17$11.4B$11.7B Details
4/29/21 Q121 $1.40$1.63 -$0.23$12.1B$12.66B Details
2/4/21 Q420 $1.32$1.38 -$0.06$12.5B$12.68B Details